Sg Americas Securities, LLC Ascendis Pharma A/S Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Sg Americas Securities, LLC holds 33,944 shares of ASND stock, worth $4.06 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

33,944

Previous 2,221 1428.32%

Holding current value

$4.06 Million

Previous $332,000 1307.53%

% of portfolio

0.02%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$122.0 - $146.6 $3.87 Million - $4.65 Million	31,723 Added 1428.32%	33,944 $4.67 Million
Q3 2024 Oct 03, 2024	SELL	$113.0 - $153.43 $439,231 - $596,382	-3,887 Reduced 63.64%	2,221 $332,000
Q2 2024 Jul 12, 2024	BUY	$121.07 - $153.67 $509,099 - $646,182	4,205 Added 220.97%	6,108 $833,000
Q1 2024 May 06, 2024	BUY	$123.45 - $159.4 $234,925 - $303,338	1,903 New	1,903 $288,000
Q1 2023 Apr 28, 2023	BUY	$104.9 - $126.78 $2.67 Million - $3.22 Million	25,417 Added 121.44%	46,347 $4.97 Million
Q4 2022 Feb 02, 2023	BUY	$99.42 - $131.97 $1.97 Million - $2.62 Million	19,838 Added 1816.67%	20,930 $2.56 Million
Q3 2022 Oct 31, 2022	BUY	$84.03 - $110.23 $91,760 - $120,371	1,092 New	1,092 $113,000
Q2 2022 Jul 29, 2022	SELL	$78.08 - $117.61 $73,551 - $110,788	-942 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$102.18 - $135.75 $14,509 - $19,276	142 Added 17.75%	942 $111,000
Q4 2021 Feb 07, 2022	SELL	$127.1 - $169.66 $311,903 - $416,345	-2,454 Reduced 75.41%	800 $108,000
Q3 2021 Nov 01, 2021	BUY	$112.67 - $176.92 $81,911 - $128,620	727 Added 28.77%	3,254 $519,000
Q2 2021 Aug 12, 2021	BUY	$121.62 - $145.29 $307,333 - $367,147	2,527 New	2,527 $332,000
Q1 2021 May 13, 2021	SELL	$124.92 - $173.33 $246,217 - $341,633	-1,971 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$151.2 - $182.76 $121,564 - $146,939	804 Added 68.89%	1,971 $329,000
Q3 2020 Nov 09, 2020	BUY	$134.29 - $154.32 $156,716 - $180,091	1,167 New	1,167 $180,000
Q2 2020 Jul 20, 2020	SELL	$110.87 - $156.01 $245,355 - $345,250	-2,213 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$97.01 - $145.11 $170,543 - $255,103	-1,758 Reduced 44.27%	2,213 $249,000
Q4 2019 Jan 28, 2020	SELL	$91.45 - $139.12 $564,703 - $859,066	-6,175 Reduced 60.86%	3,971 $552,000
Q3 2019 Nov 04, 2019	SELL	$95.8 - $118.9 $275,999 - $342,550	-2,881 Reduced 22.12%	10,146 $977,000
Q2 2019 Jul 29, 2019	BUY	$107.11 - $132.09 $1.17 Million - $1.44 Million	10,939 Added 523.9%	13,027 $1.5 Million
Q1 2019 Apr 29, 2019	BUY	$62.15 - $129.99 $14,543 - $30,417	234 Added 12.62%	2,088 $246,000
Q4 2018 Feb 01, 2019	BUY	$55.16 - $69.67 $102,266 - $129,168	1,854 New	1,854 $116,000
Q3 2018 Nov 06, 2018	SELL	$63.77 - $76.28 $730,867 - $874,245	-11,461 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$58.55 - $73.92 $671,041 - $847,197	11,461 New	11,461 $762,000

Others Institutions Holding ASND

# of Institutions

238

Shares Held

58.7M

Call Options Held

205K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $6.67B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Ascendis Pharma A/S Transaction History